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Abstract
Background: The immune response against tuberculosis in lions is still poorly defined and our understanding is
hampered by the lack of lion specific reagents. The process for producing antibodies against a specific antigen is
laborious and not available to many research laboratories. As the search for antibody cross-reactivity is an important
strategy for immunological studies in veterinary medicine, we have investigated the use of commercially available
antibodies to characterize T cell subsets in African lions (Panthera leo).
Results: Commercially available antibodies were screened and investigated the influence of two different sample
processing methods, as well as the effect of time delay on cell surface marker expression on lion lymphocytes.
Using commercially available antibodies, we were able to identify CD4+, CD5+, CD8+, CD14+, CD25+, CD44+ and
CD45+ T lymphocytes in samples obtained by density gradient centrifugation as well as red cell lysis of lion whole
blood. Two distinct lymphocyte populations, which differed in size and phenotype, were observed in the samples
processed by density gradient centrifugation.
Conclusion: Commercially available antibodies are able to differentiate between T lymphocyte subsets including
immune effector cells in African lion whole blood, and possibly give insight into unique specie phenotypes.
Keywords: African lion, Flow cytometery, Immunophenotype, Panthera leo
Background
The immune system is a complex and multi-faceted sys-
tem which includes components such as memory and
self-regulation. Flow cytometry is a commonly used tool
in immunological research, making use of fluorophore
-labelled antibodies to detect specific proteins expressed
intracellularly and on cell membranes [1]. This tech-
nique is used to monitor immune responses to infection,
track the phenotypic and functional characteristics of
antigen-specific cells, and has more recently been used
for the routine clinical diagnosis, prognosis and moni-
toring of disease [1].
Understanding the influence of pathogens, such as
Mycobacterium bovis and feline immunodeficiency virus
(FIV), opportunistic organisms and environmental het-
erogeneity on wild lion populations is crucial as the loss
of these apex predators can have devastating effects on
the ecosystems they inhabit [2]. Despite this, there is
currently little known about how health and immunity
are shaped by M. bovis and FIV co-infection when the
environment and the host and pathogen genotypes vary.
Knowledge of comparative immunology of wildlife can
further facilitate our understanding of the interactions
between host responses, ecology, evolution and health
[3]. Generally, wildlife populations have a high degree of
genetic variation which affects the robustness of the
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immune response, possibly making investigations in
these populations more reflective of what happens in
humans compared to laboratory models [4]. However,
research in non-model animal species, in particular
those living in the wild [5] or wildlife species who may
be reservoirs for disease, a lack of species specific
reagents limit our current ability to easily characterize
immune phenotypes in these species [6, 7]. For this rea-
son the de novo manufacturing of reagents or the evalu-
ation of cross-reactive antibodies from related domestic
species are needed to study species such as wild felids.
Because no commercial antibodies have specifically been
produced for use in flow cytometry in lions, the investi-
gation and characterization of immune cell phenotypes
in this species remains challenging. Despite these issues,
through the use of cross-reactive antibodies, researchers
have shown that FIV infection in lions is associated with
lower levels of circulating CD4-positive T cells [8–10] as
well as an increase in the CD8βhigh subset [9, 10].
The aim of this study was to identify commercially
available antibodies that can be used for flow cytometry
in Panthera species. Furthermore, we sought to compare
the effects of density gradient centrifugation and red cell
lysis of whole blood on the binding of these antibodies,
as well as investigate the effect of time delay on the
staining patterns of these antibodies.
Results
The scatter plots of SSC versus FSC for lion and tiger per-
ipheral blood leukocytes revealed distinct cell populations
similar to that of other mammals (Fig. 1). Based on these
scatter parameters, the percentages of lymphocytes in
PBMCs on day 1 were 33.0, 20.9% and 30.3 for lion 1, lion
2 and the tiger, respectively. The percentages of lympho-
cytes in RCLLs were 24.9, 17.8, and 10.6% in lion 1, lion 2
and the tiger, respectively. In scatterplots of PBMCs, but
not RCLLs, from all three animals, small and large lym-
phocytes appeared as distinct populations (Fig. 1).
Reactivity with lion leukocytes
All antibodies (described in Table 1) with the exception of
CD4 (clone SK3), CD4 (clone RPA-T4), CD19 (clone
SJ25C1), CD19 (clone MB19–1), CD62L (clone DREG-56)
and IgM (clone G20–127) showed clear cross-reactivity
with lion and tiger leukocyte populations in PBMCs
(Additional file 1: Figure S1) and RCLLs (Additional file 1:
Figure S2).
Staining pattern
The two distinct PBMC lymphocyte populations differed
both in size and antibody staining characteristics. The
smaller lymphocytes were mainly cells staining CD4+,
whereas the larger lymphocytes were predominantly
CD8+ cells (Fig. 2; Table 2). Small CD4+ cells were pri-
marily CD5−/CD45+, while large CD4+ cells were pri-
marily CD5+/CD45− (Fig. 3, Table 3), which is similar to
the pattern observed in CD8+ cells (Fig. 4, Table 4). The
CD4:CD8 ratio in total lymphocytes in PMBCs of Lion
1, Lion 2 and the tiger were 3.5, 7.1 and 1.8, respectively.
The predominant CD4+ subsets identified in the small
and large lymphocytes were CD5−CD45+ and CD5+CD45−
respectively. These populations were gated on in both
PBMCs (small and larger lymphocytes combined) and
RCLLs to analyse CD25+ and CD44+ expression. In the
PBMC sample, 48.4% of the CD4+CD5+CD45− cells were
CD25+, however this pattern was not mirrored in the
RCLL sample (Additional file 1: Table S1). CD44+ cells
were observed in both PBMCs and RCLLs, but the expres-
sion varied greatly.
Expression of CD14 and CD11b were restricted to
lymphocytes that were CD4+, while CD8+ lymphocytes
showed no evidence of CD14 or CD11b expression.
Moreover, CD14 and CD11b were primarily expressed
on different CD4+ sub-populations (Fig. 5, Table 5).
Influence of blood processing technique on staining
pattern
CD4 and CD8 antibody staining was comparable in the
PBMC and RCLL samples of both lions and the tiger.
The staining of CD25, CD14 and CD11b all showed
large differences between PBMC and RCLL samples for
the two lions, but were comparable for the tiger










Fig. 1 Representative flow cytometric dot plot of peripheral blood
cell sorting. Forward scatter (FSC) versus side scatter (SSC) dot plots
of PBMCs from a lion showing two distinct lymphocyte populations
(total lymphocytes circled)
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Table 1 Commercially available antibodies screened for cross-reactivity with African lion lymphocytes
Surface
marker
Clone Reactivity Fluorophore Company Optimal conc (ug/ml)
PBMC RCLL
CD5 f43 Feline/ Lion (PBMC) PE Southern Biotech,
Birmingham, AL, USA
0.5 0.5
CD4 3-4f4 Feline FITC Southern Biotech 1.75 1.75
CD4 SK3 Human APC BD Biosciences NBa NB
CD4 RPA-T4 Human V500 BD Biosciences NB NB
CD8β fCD8 Feline FITC Southern Biotech 0.25 1.75
PE Southern Biotech 0.25 3.5
CD11B M1/70 Mouse, Human PERCP-CY5.5 Abcam, Cambridge, UK 1.75 3.5
CD14 61D3 Human, Cynomolgus,
Canine, Hooded Seal
APC-CY7 Southern Biotech 3.5 1.75
CD19 SJ25C1 Human BV510 BD Biosciences NB NB
CD19 MB19–1 Mouse, Canine APC-CY7 Life Technologies, Carlsbad,
CA, United States
NB NB
CD25 P4A10 Canine Biotin/HRP-HV500 Bio-rad, Hercules, CA,
United States
0.5 1.75
CD44 IM7 Mouse PERCP-CY5.5 Southern Biotech 5 5
CD45R RA3-6B2 Mouse, Human APC-CY7 Southern Biotech 2.5 2.5
CD62L DREG-56 Human, Chimpanzee, Cattle V450 BD Biosciences NB NB
IgM G20–127 Human BV510 BD Biosciences NB NB
aAntibodies that did not bind to lion PBMC Peripheral blood mononuclear cells or RCLLs Red cell lysis leukocytes are indicated in the optimal concentration
























Fig. 2 Representative flow cytometeric scatter plots of PBMCs from a lion indicating the occurrence of two distinct lymphocyte populations. The
smaller lymphocytes are mainly comprised of a CD4+ cells, whereas b CD8+ cells make up the larger lymphocytes
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Effect of time delay on cell surface staining
The expression of surface markers over time varied
greatly between animals, with relatively stable expression
over Day 1 and Day 2 in some markers (i.e. Lion 1
PBMC CD4+ expression) but not in others (i.e. Lion 1
PBMC CD25+ expression) (Additional file 1: Tables S3,
S4 and S5). The most stably observed populations were
both PBMC and RCLL CD8+ cells, as well as
CD4+CD5−CD45+ PBMCs.
Discussion
Lymphocytes from both lions and a tiger, isolated by
centrifugation over a density gradient, separated into
distinct small and large populations. This phenomenon
has previously been described in domestic cats [13], but
not in lions [8–10, 14]. The smaller lymphocytes were
predominantly characterized as CD4+, whereas the larger
lymphocyte population was mostly CD8+ cells. This dif-
fers from what is seen in domestic cat lymphocytes,
which have a higher proportion of CD8+ cells in the
small lymphocyte population [13]. In the total PBMC
lymphocyte population the CD4:CD8 ratio varied greatly
between the three animals, with both lions having simi-
lar or higher ratios than previously reported for healthy
African lions [10, 15]. Unlike previous reports of distinct
CD8β dim and bright cells observed in [9, 10], these
subsets were not detected in the present study.
In the present study, CD45, classically known as a
pan-lymphocyte marker [16, 17], did not react with all
Panthera lymphocyte populations. Studies have reported
that CD45R is found on B cells, T cells and thymocytes
[18]. The expression of CD45R is particularly noted on
activated murine T cells [18, 19]. As T lymphocytes ex-
press various forms of the leukocyte-common antigen
CD45 [19], it is plausible that the CD45- lymphocytes
express another isoform of CD45 that was not detected.
Additionally, on CD4+ and CD8+ lymphocytes, CD5 and
CD45 did not co-localize, with the smaller lymphocytes
predominantly being CD5−CD45+ and the larger lym-
phocytes CD5+CD45−. Other authors have considered
CD5− lion lymphocytes as B cells [10], neglecting the
possibility of species specific differences in immune cell
surface receptor expression as observed in adult rabbits
where all peripheral B lymphocytes express CD5 [20].
This may have led to an over or underestimation of the
true percentage of CD4+ lymphocytes, as only CD5+
lymphocytes were considered, excluding any cells which
Table 2 CD4 and CD8 expression (%) on small and large lion
and tiger lymphocytes in PBMC sample at Day 1
Total lymphocytes Small lymphocytes Large lymphocytes
CD4+ CD8+ CD4+ CD8+ CD4+ CD8+
Lion 1 51.9 14.8 69.0 5.06 14.5 21.5
Lion 2 52.9 7.5 48.3 4.60 7.03 12.5
Tiger 26.4 14.5 39.2 13.9 1.59 18.0
Fig. 3 Representative flow cytometric dot plot of lion PBMCs. CD4 + CD5 + CD45- and CD4 + CD5-CD45+ lymphocytes were selected for back
gating to establish their distribution across the two distinct lymphocyte populations observed on the FSC versus SSC dot plots
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may be CD5−CD4+. Previous studies have described
cytotoxic CD3+CD5−CD4+ cells in humans [21] and acti-
vated CD5−CD4+ and CD5−CD8+ cells in ovine lenti-
virus infected sheep [22]. In Panthera species, markers
of activation may be similar, and the expression of CD5,
CD45 and CD4 should be investigated further.
Evidence for a highly stable subset of CD8+CD5− cells
has been described in humans [23]. These cells are a
major source of lymphotactin which is a chemotactic
agent for lymphocytes and may play a role in immune
regulation [23]. In the present study the majority of
CD8+ lymphocytes were identified as CD8+CD5−CD45+
or CD8+CD5+CD45−, which has not been previously
reported in studies characterizing the immunophenotype
of lion cells [8–10, 14]. These cells may play an import-
ant role in immune regulation and should be investi-
gated further.
The co-expression of CD4 and CD14 on the surface of
lion lymphocytes was unexpected. Although these may
be CD4+CD14+ lymphocytes, CD4+CD14+ macrophages
have been observed in both humans and rats [24, 25].
These macrophages have been described to play a role
in HIV pathogenesis [25] and may be involved in
immune responses to FIV in lions. CD8+CD14+ lympho-
cytes have been identified in humans, but not murine,
lymphocytes after stimulation and these are able to
secrete high levels of interferon gamma, granzyme and
perforin [25]. In the present study there was no evidence
of CD14 or CD11b expression on CD8+ cells, however
both CD4+CD11b+ and CD4+CD14+ lymphocytes were
observed. The CD11b adhesion protein is associated
with T cell activation, and its expression on T cells has
been associated with persistent bacterial infection
[25]. Conversely, CD11b expression on CD8+ cells are
characteristic of viral infections [26]. The current
study is the first to describe the expression of CD14
and CD11b on lion lymphocytes. However, a study investi-
gating the effects of FIV on T lymphocyte populations
Table 3 CD5 and CD45 expression on small and large CD4+ cells in Panthera PBMCs (%) at Day 1 as determined by flow cytometry
Small lymphocytes Large lymphocytes
CD5+ CD5− CD5+ CD5−
CD45− CD45+ CD45− CD45+ CD45− CD45+ CD45− CD45+
Lion 1 14.5 4.55 19.5 61.4 56.6 4.3 4.9 32.9
Lion 2 10.0 6.7 19.8 63.3 29.3 8.1 8.4 54.2
Tiger 46.2 13.8 3.28 36.8 62.1 1.5 2.2 34.2
Fig. 4 Representative flow cytometric dot plot of lion PBMCs. CD8 + CD5 + CD45- and CD8 + CD5-CD45+ lymphocytes were selected for back
gating to establish their distribution across the two distinct lymphocyte populations observed on the FSC versus SSC dot plots
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described the expression of CD18, which associates
with the 11b integrin chain [27]. Higher expression of
CD18, defined as a marker of activation, has also
been observed on CD8+ T cells in FIV-positive lions
[9], supporting the increased expression of integrins
on virally activated cells. These markers should be in-
vestigated further, and may provide insights into the
mechanism of immune regulation in M. bovis or FIV
infection.
Previous immunophenotyping studies using lion per-
ipheral blood have investigated the influence of FIV on
CD44 and CD49 as activation markers [9]. In the
present study however, we describe the novel identifica-
tion of CD4+CD25+ cells in lion PBMCs and RCLLs,
with staining patterns similar to that of regulatory T
cells in domestic cats [28]. Lion CD44+ lymphocytes
have also been characterized in the present study using
a canine cross-reactive clone, IM7. A previous report
described the use of CD44 clone MEM85 in lions, and
found CD44 expression to remain unchanged by FIV
[9]. The genetic sequence coding for these two clones
have been found to be homoglous with different regions
of the CD44 gene [29]. Furthermore, the antibody from
the MEM85 clone is reported to bind to human CD44,
but not canine CD44, whereas the antibody from the
IM7 clone was described to be cross-reactive with
mouse, dog, non-human primates and humans [29].
CD44 is essential for the generation of memory Th1
cells [30] and also plays a role in cell adhesion and mi-
gration, lymphocyte homing, activation and prolifera-
tion [31]. In FIV-infected domestic cats, Th1 immune
responses have been shown to inhibit virus replication
[32]. Investigating the co-localization of IM7 and
MEM85 may increase confidence and improve insight
Table 4 CD5 and CD45 expression on small and large CD8+ cells in Panthera PBMCs (%) at Day 1 as determined by flow cytometry
Small lymphocytes Large lymphocytes
CD5+ CD5− CD5+ CD5−
CD45− CD45+ CD45− CD45+ CD45− CD45+ CD45− CD45+
Lion 1 19.0 18.1 3.7 59.2 49.5 7.43 8.8 34.3
Lion 2 33.9 24.2 7.37 34.5 40.9 16.4 9.6 33.0
Tiger 62.9 19.9 7.7 9.52 78.4 7.89 4.2 9.6
Fig. 5 Flow cytometric dot plot of peripheral blood cell sorting. CD4 + CD8- (a), CD4 + CD8+ (b) and CD4-CD8+ (c) lymphocyte subsets were
selected to evaluate CD14 and CD11b expression
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into the effects of FIV on the CD44+ directed immune
activation in lion lymphocytes.
Due to the remote locations where wild lion popula-
tions are found as well as the harsh in-field conditions,
the influence of both time to processing as well as the
influence of different sampling methods were investi-
gated. The effects of sample processing varied greatly be-
tween the animals, with CD4 and CD8 antibody staining
being comparable between the PBMC and RCLL sam-
ples of both lions and the tiger. Although staining
patterns using CD25, CD14 and CD11b in PBMCs and
RCLLs were similar in the tiger, they were not in the
lions. Previous reports of flow cytometric analysis of
T-lymphocyte subsets in cats report that fluorescence in-
tensity was not adversely affected by the whole blood
lysis technique [12]. Moreover, the influence of sample
processing time on antibody binding was inconclusive,
with highly variable patters observed. Further investiga-
tion in a larger cohort of animals is required to establish
the usefulness of the whole blood lysis technique in lion
whole blood, as well as the influence of processing time
on antibody binding to cell surface markers. Further val-
idation of the reactivity of these antibodies in Pathera
species using transcriptomics will prove useful in con-
firming and clarifying the lymphocyte subsets observed.
Moreover, as FIV infection has been reported to
influence the distribution of small and large lymphocytes
in domestic cats [13], it may be useful to further investi-
gate lymphocyte activation in these populations in
infected lions.
The role of T-lymphocytes in the lion immune re-
sponse are poorly understood. To our knowledge, this is
the first published report on the flow cytometric analysis
of tiger lymphocytes and the use of these commercially
obtained antibodies in lion RCLLs. Additionally, we de-
scribe the presence of possible activated subsets within
these samples which may give insight into the mechan-
ism of immune protection during pathogenic infections.
A number of previous studies have investigated lion
lymphocyte populations by using commercially available
antibodies developed for the domestic cat [8–10, 14, 33],
demonstrating the conserved nature of cell surface epi-
topes among felids and the usefulness of using domestic
cat-specific antibodies in lions [8].
Conclusion
This study shows that commercially obtained anti-
bodies are able to recognise cell surface markers in
both lion PBMCs and RCLLs, and that there is sub-
stantial loss of signal over time, advocating for the
timely processing of samples for immunophenotyping.
This paper provides a platform which may enable fu-
ture immune-phenotyping studies to investigate the
immune response to FIV and M. bovis infections,
pathogens commonly affecting the lion populations in
South Africa.
Methods
Animals and sample collection
Two captive lions (Panthera leo) and one captive tiger
(Panthera tigris) were opportunistically sampled from a
private game reserve in the Free State, South Africa, dur-
ing routine health examinations. Blood samples were
collected by jugular venipuncture into sodium heparin
blood collection tubes and stored at room temperature
for 1, 2 and 3 days, respectively (Fig. 6). Approval for this
study was obtained from the Stellenbosch University
Animal Care and Use Committee (SU-ACUD15–00013).
Permission to use the blood obtained from these animals
was granted bu. the Head of Animal Welfare at Lions-
Rock Big Cat Sanctuary.
Blood processing
Two sample processing methods to obtain lymphocytes
from whole blood were compared in order to establish
whether antibody binding or cell surface receptor ex-
pression and detection were influenced by either
method.
Red cell lysis of whole blood
Five hundred microliter aliquots of whole blood har-
vested on Day 1, 2 and 3 were incubated with 1 ml of
Red Cell Lysis Buffer (BD Bioscience, San Jose, CA,
USA) in the dark for 10 min, at room temperature. Cells
were harvested by centrifugation at 450 x g for 5 min
and washed three times with flow cytometry staining
buffer (phosphate-buffered saline (PBS) containing 2%
foetal bovine serum (FBS) (Capricorn Scientific, Ebsdor-
fergrund, Germany), then resuspended and stored in
cryopreservation media consisting of 90% FBS and 10%
dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Louis,
MO, USA) as three aliquots at − 80 °C. Cell staining was
performed within 6 months. Samples obtained using this
method will hereafter be referred to as red cell lysis
leukocytes (RCLLs).
Density gradient centrifugation
On Day 1, 2 and 3, 10 ml of whole blood was diluted 1:1
with sterile PBS and layered on 20ml of Ficoll-Paque (GE
Table 5 CD14 and CD11b expression (%) on CD 4+ and CD8+
cells in Panthera PBMCs at Day 1 as determined by flow
cytometry
CD4+CD8− CD4+CD8+ CD4−CD8+
CD14+ CD11b+ CD14+ CD11b+ CD14+ CD11b+
Lion 1 4.56 2.34 3.92 0 0 0
Lion 2 3.86 0.97 1.55 3.10 0 0
Tiger 5.63 2.33 0.56 0 0 0
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Healthcare Bio-Sciences, Uppsala, Sweden). Samples
were centrifuged for 25 min at 400×g, without apply-
ing a brake. The peripheral blood mononuclear cell
(PBMC) interface was carefully aspirated and cells
were washed twice with PBS by centrifugation for 10
min at 400×g. The PBMCs were resuspended in re-
sidual PBS and stored in cryopreservation media as
three aliquots at − 80 °C until staining was performed.
Cell staining was performed within 6 months. Samples ob-
tained using this method will hereafter be referred to as
PBMCs.
Cell surface receptor staining
Cells stored at − 80 °C were thawed in a water bath at
37 °C and washed twice with staining buffer before being
resuspended in 4ml staining buffer. During initial
optimization, 50 μl of resuspended cells were incubated
with dilutions of fluorophore-labelled antibody (1:5,
1:10, 1:25, 1:50, 1:100 and 1:200), with final concentra-
tions of antibody at 0.25–5 μg/ml (Table 1). The optimal
antibody concentration was determined as previously
described [9]. The cells were stained at the optimal con-
centration for 60 min at 4 °C in the dark, with manual
agitation 30min into the staining protocol. After stain-
ing, cells were washed according to manufacturer’s in-
structions. A FACS Canto II (BD Bioscience) was used
for cell acquisition (≥10,000 events). The instrument was
calibrated and setup according to the manufacturer’s
instructions. Quality controls included the use of
Rainbow Beads (eBioscience—San Diego, CA, USA) and
BD™ CompBeads to adjust the compensation settings
accordingly.
Gating strategy
In order to identify lymphocyte populations, doublets
were excluded using forward scatter (FSC) area versus
FSC height as previously described [11]. Following
exclusion of debris, lymphocyte subsets were identified
and other cell types, including monocytes, excluded
based on FSC and side scatter (SSC) characteristics, as
for other species [11, 12]. From this gate, CD4+, CD4−,
CD8+ or CD8− T lymphocytes were selected for further
analysis depending on the panel analysed. The PBMCs
and RCLLs were stained with three different antibody
combinations: Panel 1: CD5, CD4, CD25, CD44, CD45;
Panel 2: CD4, CD8, CD14, CD11b; and Panel 3: CD 5,
CD8, CD45. The initial strategy first gated on all CD45+
cells (as is the standard approach), however due to large
proportion of the lymphocytes being excluded from the
analysis, as well as the observation of a large subset of
CD4+ cells which did not express CD45, the gating
strategy was changed to the above. Based on our current
understanding of the human immune system we do not
expect CD4+ cells to not express CD45, but due to spe-
cies specific differences observed by other authors [20]
this possibility in lions cannot be ruled out.
Data and statistical analysis
All data were analysed using FlowJo Version 10 software
(Tree Star, Ashland, OR, USA). Nonparametric tests
(Mann-Whitney U tests) were used to compare antibody
staining patterns over time. A p-value of 0.05 or less was
considered significant. All statistical analyses were per-
formed using GraphPad Prism version 5.00 (GraphPad
Software, Inc., La Jolla, CA, USA).
















Samples were stored in cryopreservation media (90% FBS and 10% DMSO) 
at -80°C until analysed
Fig. 6 Whole blood was collected in sodium heparin tubes and stored at room temperature until processed. Samples were processed on Day 1
(within 24 h of collection), Day 2 (within 48 h of collection) and Day 3 (within 72 h of collection), by both red cell lysis (RCL) of the whole blood
and density gradient centrifugation (DGC). The processed samples were stored in cryomedia, containing foetal bovine serum (FBS) and dimethyl
sulfoxide (DMSO), at − 80 °C
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Additional file
Additional file 1: Figure S1. Staining profiles for commercially available
antibodies a) CD4, b) CD8, c) CD44, d) CD5, e) CD45, f) CD25, g) CD14
and h) CD11b that showed evidence of cross-reactivity with Panthera
lymphocytes in the PBMC sample. Figure S2. Staining profiles for com-
mercially available antibodies a) CD4, b) CD8, c) CD44, d) CD5, e) CD45, f)
CD25, g) CD14 and h) CD11b that showed evidence of cross-reactivity
with Panthera lymphocytes in the RCLL sample. Table S1. CD44 and
CD25 expression on CD4 + CD5 + CD45- and CD4 + CD5-CD45+ lympho-
cytes in PBMCs and RCLLs (%) at Day 1. Table S2. Expression of cell sur-
face markers (%) in Panthera species PBMCs versus RCLLs on Day 1. Table
S3. Cell surface marker expression (%) on lymphocytes in PBMC and RCLL
samples of Lion 1 over time. Table S4. Cell surface marker expression (%)
on lymphocytes in PBMC and RCLL samples of Lion 2 over time. Table
S5. Cell surface marker expression (%) on lymphocytes in PBMC and RCLL
samples of the tiger over time. (PDF 456 kb)
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